Bluebird bio, Inc. Blog | Talkmarkets

Article By: Benzinga

Friday, November 1, 2019 7:38 AM EDT

Here's a roundup of top developments in the biotech space over the last 24 hours.

In this article: AMGN, BGNE, MNK, PRTK, IDYA, CDNA, BLUE Also: HOTH, AGN, AZN, BMY, GSK, RMD, ACOR, ACRX, ALIM, AMAG, BCRX, CERS, IMGN, NURO, RMTI, CELG, VRTX, ABBV, AGIO, REPH, RETA, PRTO, MGNX, OPGN, MGEN, DOVA, DRNA, DCPH, TRVI, OYST, RAPT, ARDS, MIRM, ITRM, COCP, CYCN, GMAB

Article By: T.J. Hayes

Monday, September 9, 2019 7:36 PM EDT

The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.

In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB

Article By: Rod Raynovich

Friday, March 22, 2019 7:17 AM EDT

Mid-Cap biotech stocks ran up today along with a broad market rally in tech stocks with the NAZ up 1.42% and the XLK up 2.51%.

In this article: NAZ, RHHBY, BLUE, BIIB, XLK, ACIU

Article By: Rod Raynovich

Thursday, February 28, 2019 12:20 PM EDT

Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%.

In this article: ONCE, RARE, DHR, GE, XBI, BLUE, CRSP, IWM, XLV, MRK, RHHBY, BMY, CELG, LOXO, LLY, GNMK, AMRN, TDOC

Article By: Zacks Investment Research

Wednesday, January 23, 2019 2:06 PM EDT

There are multiple drug/biotech companies poised to beat on fourth-quarter earnings.

In this article: CELG, REGN, AMGN, ALNY, BLUE Also: BMY, LLY, LOXO